Quotes 5-day view Delayed Nyse | |
|
06/27/2022 |
06/28/2022 |
06/29/2022 |
06/30/2022 |
07/01/2022 |
Date |
225.49(c) |
217.5(c) |
219.46(c) |
213.97(c) |
218.83(c) |
Last |
355 390 |
320 335 |
381 197 |
596 926 |
275 655 |
Volume |
-0.37% |
-3.54% |
+0.90% |
-2.50% |
+2.27% |
Change |
|
|
Estimated financial data (e) (USD) |
|
Sales 2022 |
4 026 M
-
-
|
Net income 2022 |
450 M
-
-
|
Net Debt 2022 |
2 232 M
-
-
|
P/E ratio 2022 |
25,4x |
Yield 2022 |
- |
|
Sales 2023 |
4 466 M
-
-
|
Net income 2023 |
579 M
-
-
|
Net Debt 2023 |
1 756 M
-
-
|
P/E ratio 2023 |
19,9x |
Yield 2023 |
- |
|
Capitalization |
11 118 M
11 118 M
-
|
EV / Sales 2022 |
3,32x |
EV / Sales 2023 |
2,88x |
Nbr of Employees |
19 300 |
Free-Float |
98,8% |
|
|
|
Ratings of Charles River Laboratories International, Inc. |
|
|
|
All news about CHARLES RIVER LABORATORIES INTERNATIONAL, INC. |
|
|
|
News in other languages on CHARLES RIVER LABORATORIES INTERNATIONAL, INC. |
|
|
|
Analyst Recommendations on CHARLES RIVER LABORATORIES INTERNATIONAL, INC. |
|
|
|
|
|
|
Western businesses cut some Russia ties over Ukraine invasion |
Chart CHARLES RIVER LABORATORIES INTERNATIONAL, INC. |
|
Duration :
Period :
|
 |
|
Technical analysis trends CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
| Short Term | Mid-Term | Long Term | Trends | Neutral | Bearish | Bearish |
Income Statement Evolution
|
Mean consensus |
BUY |
Number of Analysts |
16 |
Last Close Price |
218,83 $ |
Average target price |
326,85 $ |
Spread / Average Target |
49,4% |
|